| HGNC Family | Immunoglobulin superfamily domain containing, CD molecules (CD) |
| Name | leukocyte-associated immunoglobulin-like receptor 2 |
| Description | The protein encoded by this gene is a member of the immunoglobulin superfamily. It was identified by its similarity to leukocyte-associated immunoglobulin-like receptor 1, a membrane-bound receptor that modulates innate immune response. The protein encoded by this locus is a soluble receptor that may play roles in both inhibition of collagen-induced platelet aggregation and vessel formation during placental implantation. This gene maps to a region of 19q13.4, termed the leukocyte receptor cluster, which contains 29 genes in the immunoglobulin superfamily. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2013] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LAIR2 is a soluble homolog of the transmembrane inhibitory receptor LAIR‑1 that binds collagens with high affinity. Because its affinity for collagen exceeds that of LAIR‑1, LAIR2 functions as a natural decoy receptor, antagonizing LAIR‑1–mediated inhibitory signals and thereby modulating immune cell function."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": " In several experimental models, recombinant LAIR2‐Fc proteins can efficiently block collagen interactions not only with LAIR‑1 but also with other collagen receptors, thereby relieving collagen‐induced inhibition of immune responses, interfering with platelet activation, and even modulating complement fixation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "7"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its role in antagonizing LAIR‑1, LAIR2 is emerging as an important immunomodulatory molecule in various disease settings. Altered expression levels and genetic variants of LAIR2 have been linked to autoimmune disorders (including autoimmune thyroid diseases and pemphigus foliaceus) and inflammatory conditions, where increased LAIR2 may counterbalance excessive inhibitory signals and serve as a potential biomarker of inflammation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "11"}]}, {"type": "t", "text": " In oncology, aberrant LAIR2 expression has been observed in tumor samples from renal cell carcinoma, cholangiocarcinoma, lung adenocarcinoma, and cutaneous T‐cell lymphoma, suggesting that LAIR2 may influence the tumor microenvironment by modulating immune cell infiltration and function; indeed, high LAIR2 levels often correlate with more aggressive disease or resistance to certain therapies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "16"}]}, {"type": "t", "text": " \n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In the context of pregnancy, LAIR2 is expressed at the maternal–fetal interface. Its highly restricted expression in extravillous trophoblasts and in areas critical for spiral arteriole remodeling indicates that LAIR2 may regulate trophoblast invasion and vascular adaptation, with altered expression being associated with adverse outcomes such as preeclampsia."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "20"}]}, {"type": "t", "text": " Moreover, studies in placental models further demonstrate that LAIR2 can modulate decidual natural killer cell function by interfering with LAIR‑1–collagen interactions, a mechanism that might contribute to the maintenance of immune tolerance during early pregnancy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, advances in detection methodologies – including the generation of monoclonal antibodies against LAIR2 – have improved our ability to study its distribution and function in diverse biological fluids such as plasma, urine, and synovial fluid. These technical developments not only support the utility of LAIR2 as a biomarker reflecting systemic inflammation but also underscore its potential as a target for novel immunotherapeutic strategies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, LAIR2 serves as a key immunomodulator by acting as a decoy receptor that interferes with collagen binding to LAIR‑1, thereby regulating inhibitory signaling across a variety of physiological and pathological settings, including immune homeostasis, tumor immunity, and placental development.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Myoungsun Son, Frances Santiago-Schwarz, Yousef Al-Abed, et al. "}, {"type": "b", "children": [{"type": "t", "text": "C1q limits dendritic cell differentiation and activation by engaging LAIR-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1212753109"}], "href": "https://doi.org/10.1073/pnas.1212753109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23093673"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23093673"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Robert Jan Lebbink, Maaike C W van den Berg, Talitha de Ruiter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen/LAIR-1 inhibitory immune interaction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.180.3.1662"}], "href": "https://doi.org/10.4049/jimmunol.180.3.1662"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18209062"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18209062"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Robert Jan Lebbink, Nicolas Raynal, Talitha de Ruiter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Matrix Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.matbio.2009.03.005"}], "href": "https://doi.org/10.1016/j.matbio.2009.03.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19345263"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19345263"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Natalia Gómez-Lozano, Ernesto Estefanía, Fionnuala Williams, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.200425493"}], "href": "https://doi.org/10.1002/eji.200425493"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15580659"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15580659"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Marloes J M Olde Nordkamp, Martin van Eijk, Rolf T Urbanus, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.3AB0213-092RR"}], "href": "https://doi.org/10.1189/jlb.3AB0213-092RR"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24585933"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24585933"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Peter J Lenting, Geertje H A Westerlaken, Cécile V Denis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0012174"}], "href": "https://doi.org/10.1371/journal.pone.0012174"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20730098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20730098"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Marloes J M Olde Nordkamp, Peter Boross, Cafer Yildiz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of the classical and lectin pathway of the complement system by recombinant LAIR-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Innate Immun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000354976"}], "href": "https://doi.org/10.1159/000354976"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24192271"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24192271"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Rita Simone, Giampaola Pesce, Princey Antola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum LAIR-2 is increased in autoimmune thyroid diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0063282"}], "href": "https://doi.org/10.1371/journal.pone.0063282"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23691008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23691008"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Carolina Maciel Camargo, Danillo G Augusto, Maria Luiza Petzl-Erler "}, {"type": "b", "children": [{"type": "t", "text": "Differential gene expression levels might explain association of LAIR2 polymorphisms with pemphigus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-015-1626-6"}], "href": "https://doi.org/10.1007/s00439-015-1626-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26721477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26721477"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Manuela Marchiano, Erika Iervasi, Giampaola Pesce, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased concentration of soluble leukocyte-associated immunoglobulin-like receptor in sera from patients with blistering diseases: possible pathophysiological implications?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Minerva Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.23736/S0026-4806.22.07652-2"}], "href": "https://doi.org/10.23736/S0026-4806.22.07652-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35156785"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35156785"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Marloes J M Olde Nordkamp, Joël A G van Roon, Max Douwes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis: LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Rheum (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/art.30612"}], "href": "https://doi.org/10.1002/art.30612"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22127695"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22127695"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yasutaka Yamada, Sho Sugawara, Takayuki Arai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Urol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/iju.13783"}], "href": "https://doi.org/10.1111/iju.13783"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30153702"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30153702"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Zheng Chen, Mincheng Yu, Jiuliang Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2021.647209"}], "href": "https://doi.org/10.3389/fimmu.2021.647209"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33841428"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33841428"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jared M Andrews, Jennifer A Schmidt, Kenneth R Carson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2019.07.053"}], "href": "https://doi.org/10.1016/j.ebiom.2019.07.053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31358475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31358475"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Dalam Ly, Quan Li, Roya Navab, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancers (Basel) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cancers14010205"}], "href": "https://doi.org/10.3390/cancers14010205"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35008369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35008369"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "M Ines Pascoal Ramos, Linjie Tian, Emma J de Ruiter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.62927"}], "href": "https://doi.org/10.7554/eLife.62927"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34121658"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34121658"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "S A Founds, B Fallert-Junecko, T A Reinhart, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAIR2-expressing extravillous trophoblasts associate with maternal spiral arterioles undergoing physiologic conversion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Placenta (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.placenta.2012.09.017"}], "href": "https://doi.org/10.1016/j.placenta.2012.09.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23332415"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23332415"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jianbing Liu, Haoqi Zhao, Fang Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human-specific LAIR2 contributes to the high invasiveness of human extravillous trophoblast cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reprod Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.repbio.2019.08.001"}], "href": "https://doi.org/10.1016/j.repbio.2019.08.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31548102"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31548102"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Liang Zhao, Lifang Sun, Xiuli Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In vitro fertilization and embryo transfer alter human placental function through trophoblasts in early pregnancy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2020.10971"}], "href": "https://doi.org/10.3892/mmr.2020.10971"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32319609"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32319609"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "S A Founds, B Fallert-Junecko, T A Reinhart, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAIR2 localizes specifically to sites of extravillous trophoblast invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Placenta (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.placenta.2010.07.005"}], "href": "https://doi.org/10.1016/j.placenta.2010.07.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20692035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20692035"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Qiang Fu, Yufei Sun, Yu Tao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of the JAK-STAT pathway in collagen regulation of decidual NK cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Reprod Immunol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/aji.12769"}], "href": "https://doi.org/10.1111/aji.12769"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28975683"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28975683"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Qiang Fu, Yu Tao, Hailan Piao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Trophoblasts and decidual stromal cells regulate decidual NK cell functions via interaction between collagen and LAIR-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Reprod Immunol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/aji.12211"}], "href": "https://doi.org/10.1111/aji.12211"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24548186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24548186"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Xin Xie, Zhenjie Xu, Jihong Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A non-stimulatory monoclonal antibody against the inhibitory immunoreceptor LAIR-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Monoclon Antib Immunodiagn Immunother (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/mab.2013.0062"}], "href": "https://doi.org/10.1089/mab.2013.0062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24694245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24694245"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xin Xie, ChunYan Wang, YuanQi Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development and evaluation of a sandwich ELISA method for the detection of human CD306."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol Methods (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jim.2013.07.013"}], "href": "https://doi.org/10.1016/j.jim.2013.07.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23954474"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23954474"}]}]}]}
|
| Synonyms | CD306 |
| Proteins | LAIR2_HUMAN |
| NCBI Gene ID | 3904 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LAIR2 has 2,407 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 80 datasets.
Click the + buttons to view associations for LAIR2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of LAIR2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LAIR2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of LAIR2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of LAIR2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of LAIR2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of LAIR2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of LAIR2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of LAIR2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of LAIR2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with LAIR2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of LAIR2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of LAIR2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of LAIR2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of LAIR2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of LAIR2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing LAIR2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing LAIR2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with LAIR2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with LAIR2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of LAIR2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with LAIR2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with LAIR2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with LAIR2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by LAIR2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with LAIR2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with LAIR2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with LAIR2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with LAIR2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with LAIR2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at LAIR2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of LAIR2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of LAIR2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of LAIR2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with LAIR2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing LAIR2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of LAIR2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of LAIR2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of LAIR2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of LAIR2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of LAIR2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing LAIR2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by LAIR2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of LAIR2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of LAIR2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LAIR2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with LAIR2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with LAIR2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with LAIR2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of LAIR2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of LAIR2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LAIR2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with LAIR2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with LAIR2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for LAIR2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of LAIR2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of LAIR2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of LAIR2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with LAIR2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of LAIR2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of LAIR2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of LAIR2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of LAIR2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain LAIR2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by LAIR2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting LAIR2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for LAIR2 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of LAIR2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of LAIR2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of LAIR2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving LAIR2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving LAIR2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of LAIR2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of LAIR2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of LAIR2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of LAIR2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of LAIR2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of LAIR2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of LAIR2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with LAIR2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with LAIR2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |